Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.19
Delayed Data
As of Aug 25
 -0.05 / -0.49%
Today’s Change
6.47
Today|||52-Week Range
15.03
+10.76%
Year-to-Date

Today’s Trading

Previous close10.24
Today’s open10.25
Day’s range10.08 - 10.43
Volume317,567
Average volume (3 months)478,183
Market cap$511.4M
Dividend yield--
Data as of 4:00pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)+21.43%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+16.67%
P/E ratio13.8
Price/Sales3.05
Price/Book2.82

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+2.42+20.60%
SCMPSucampo Pharmaceutic...-0.06-0.54%
LBIOLion Biotechnologies...-0.08-0.93%
KERXKeryx Biopharmaceuti...-0.09-1.91%
Data as of 4:00pm ET, 08/25/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.17
Annual revenue (last year)$157.3M
Annual profit (last year)$29.5M
Net profit margin18.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer, Secretary &
SVP-Finance
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs